The Genetic and Affective Prediction Study

Mental Disorders Clinical Trial

— GAP  

Official title:

The Genetic and Affective Prediction Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02625818
• Other study ID #: 2014/1751
• Status: Completed
• Start date: January 2016
• Est. completion date: January 2021

Study information

• Verified date: March 2021
• Source: St. Olavs Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A major proportion of patients admitted to psychiatric acute and emergency departments have symptoms, behaviors or function influenced by implicit or explicit suicidal intention (tendency towards self-harm, or suicide attempt). There is an increased risk of suicide in the acute phase during in-patient stay and after discharge. At present there is no satisfactory tool to predict post-discharge suicide risk.

Multidimensional rating is expected to have better predictive properties than one-dimensional rating for suicidal behavior during in -patient stay and two years after discharge. Multidimensional rating assesses anxiety, panic, agitation, suicidal thoughts and ideations, as well as therapist's reactions during interviews. In the present study the predictive properties of two rating scales for suicidal behavior during in-patient stay and two years after will be compared. One of these is a multidimensional scale: "Multidimensional Assessment of Suicide Risk" (MARIS).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 400
• Est. completion date: January 2021
• Est. primary completion date: January 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• acute agitated condition

• informed consent

Exclusion Criteria:

• Drug abuse

• in-patient stay for a fixed time at regular intervals

Related Conditions & MeSH terms

• Mental Disorders

Locations

Country	Name	City	State
Norway	St Olavs Hospital, Østmarka psychiatric department	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
St. Olavs Hospital	Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	self-inflicted, potentially injurious behavior with intention to die defined as acts needing attendance by physician	during in-patient stay	2 weeks
Secondary	suicide		2 years after discharge